Equillium Inc to Acquire Metacrine Inc - M&A Call Transcript
Welcome, and thank you for joining us this morning for Equillium's announcement regarding the acquisition of Metacrine Inc. Present this morning is Mr. Bruce Steel, Chief Executive Officer of Equillium; Dr. Preston Klassen, President and Chief Executive Officer of Metacrine; Dr. Stephen Connelly, Chief Scientific Officer of Equillium; and Mr. Jason Keyes, Chief Financial Officer of Equillium, who will also join for Q&A following the presentation.
Before we begin, I would like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these statements as a result of various important factors. This includes those discussed in the Risk Factors section in the company's most recent annual report on Form 10-K, as well as other reports filed with the SEC.
I'll remind you that this call is being recorded, and a replay will be available on the company's website following the conclusion of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
